A double-blind clinical trial of hydroxyethylrutosides in the treatment of the symptoms and signs of chronic venous insufficiency

Phlebology

Volumn 11, Issue 2, 1996, Pages 76-82

  Cloarec, M ^a   Clement R ^b   Griton, P ^c  

^a HÔPITAL TENON   (France)

^b SERVICE D ENDOCRINOLOGIE   (France)

^c NONE   (France)

Author keywords

Chronic venous insufficiency; Hydroxyethylrutosides; Leg circumference; Leg symptoms; Plethysmography; TcPo2

Indexed keywords

MONOXERUTIN; SCLEROSING AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANKLE; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; FLATULENCE; FRANCE; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TIME; VEIN BLOOD FLOW;

EID: 0029783828     PISSN: 02683555     EISSN: None     Source Type: Journal    
DOI: 10.1177/026835559601100210     Document Type: Article

References (16)

1. Van Cauwenberge H. Double blind study of the efficacy of O-(β-hydroxyethyl)-rutosides in the treatment of venous conditions. Med et Hyg 1978;36:4175-7.
2. Balmer A, Limoni C. A double-blind placebo controlled clinical trial of Venoruton on the symptoms and signs of chronic venous insufficiency. The importance of patient selection. Vasa 1980;9:76-82.
3. Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK. Vasa 1983;12:373-6.
4. MacLennan WJ, Wilson J, Rattenhuber V, Dikland WJ, Vanderdonckt J, Moriau M. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability. Gerontology 1994;40:45-52.
5. Roztocil K, Prerovsky I, Oliva I. The effect of hydroxyethylrutosides on capillary filtration rate in the lower limb of man. Eur J Clin Pharmacol 1977;11:435-8.
6. Cesarone MR, Laurora G, Ricci A, Belcaro G, Candiani C, Leon M. Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy. Vasa 1992;21:76-80.
7. Burnand KG, Powell S, Bishop C, Stacey M, Pulvertaft T. Effect of Paroven on skin oxygenation in patients with varicose veins. Phlebology 1989;4:15-22.
8. Neumann HAM, Van den Broek MJTB. Evaluation of O-(β-hydroxyethyl)-rutosides in chronic venous insufficiency by means of non-invasive techniques. Phlebology 1990;5(suppl 1):13-20.
9. Quigley FG, Faris IB. A study on the effect of hydroxyethylrutoside on transcutaneous oxygen tension measurements in patients with severe venous insufficiency. Vasc Surg 1991;25:42-7.
10. 2 measurements, leg volumetry and ambulatory venous pressure measurements. Phlebology 1989;4:23-9.
11. Belcaro G, Candiani C. Chronic effects of O-(β-hydroxyethyl)-rutosides on microcirculation and capillary filtration in diabetic microangiopathy. Curr Ther Res 1991;49:131-9.
12. Dikland VJ. A clinical trial of the effect of hydroxyethylrutosides on the venous refill time measured by light reflection rheography. Scripta Phlebologica 1994;3:4-7.
13. Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology and therapeutic efficacy in venous insufficiency and related disorders. Drugs 1992;44:1013-32.
14. Roztocil K. Fischer A, Novak P, Razgova I. The effect of O-(β-hydroxyethyl)-rutosides (HR) on the peripheral circulation in patients with chronic venous insufficiency. Eur J Clin Pharmacol 1971;3:243-6.
15. Razgova L, Roztocil K, Halova J, Fischer A. The effect of O-(β-hydroxyethyl)-rutosides (HR) on peripheral blood vessels in the lower extremities in idiopathic oedema. Eur J Clin Pharmacol 1971;3:247-51.
16. Bergqvist D, Hallböök T, Lindblad B, Lindhagen A. A doubleblind trial of O-(β-hydroxyethyl)-rutosides in patients with chronic venous insufficiency. Vasa 1981;10:253-60.